Pharmabiz1h
Intellia Therapeutics doses first patient in MAGNITUDE-2 phase 3 study of nexiguran ziclumeran
Intellia Therapeutics doses first patient in MAGNITUDE-2 phase 3 study of nexiguran ziclumeran: Cambridge, Massachusetts Saturday, April 5, 2025, 18:00 Hrs [IST] Intellia Therapeu ...
Pharmabiz2h
Pacira BioSciences begins patient dosing in phase 2 study evaluating safety and efficacy of PCRX-201 to treat osteoarthritis of the knee
Pacira BioSciences begins patient dosing in phase 2 study evaluating safety and efficacy of PCRX-201 to treat osteoarthritis of the knee: Brisbane, California Saturday, April 5, 2 ...
Pharmabiz11h
Reciprocal tariff may pose significant challenge to growth of medical devices sector: AiMeD
Reciprocal tariff may pose significant challenge to growth of medical devices sector: AiMeD: Our Bureau, New Delhi Saturday, ...
Pharmabiz4h
Vera Therapeutics completes full enrollment in pivotal ORIGIN phase 3 trial for Atacicept in patients with IgA nephropathy
Brisbane, California Saturday, April 5, 2025, 15:00 Hrs [IST] ...
Pharmabiz5h
Clinical Trials Information System designated as WHO primary registry
The Clinical Trials Information System (CTIS) has been designated as a primary registry by the World Health Organisation (WHO) within the International Clinical Trials Registry Platform (ICTRP).
Pharmabiz6h
EU approves AstraZeneca’s Imfinzi-in combo with chemotherapy to treat patients with resectable non-small cell lung cancer
EU approves AstraZeneca’s Imfinzi-in combo with chemotherapy to treat patients with resectable non-small cell lung cancer ...
Pharmabiz7h
NIH-supported trial shows AI screening for opioid use disorder associated with fewer hospital readmissions
NIH-supported trial shows AI screening for opioid use disorder associated with fewer hospital readmissions: Bethesda, Maryland Saturday, April 5, 2025, 12:00 Hrs [IST] An artifici ...
Pharmabiz11h
Indian healthcare sees urgent need for skill development to offset shortfall of doctors, nurses and paramedics
Nandita Vijayasimha, Bengaluru Saturday, April 5, 2025, 08:00 Hrs [IST] ...
Pharmabiz11h
WB DCA files police complaint against threatening calls to DIs to stop inspections at sale premises & supply chains
WB DCA files police complaint against threatening calls to DIs to stop inspections at sale premises & supply chains: Peethaambaran Kunnathoor, Chennai Saturday, April 5, 2025, 08: ...
Pharmabiz9h
‘Roche presents novel therapeutic and diagnostic advancements in Alzheimer’s at AD/PD 2025
Roche presents novel therapeutic and diagnostic advancements in Alzheimer’s at AD/PD 2025: Basel Saturday, April 5, 2025, 10:00 Hrs [IST] Roche announced that new data were p ...
Pharmabiz11h
Ayush ministry needs to come up with new schemes and strategies to achieve targets: Parliamentary Panel
Gireesh Babu, New Delhi Saturday, April 5, 2025, 08:00 Hrs [IST] ...
Pharmabiz8h
US FDA approves Amgen’s Uplizna to treat IgG4-related disease
US FDA approves Amgen’s Uplizna to treat IgG4-related disease: Thousand Oaks, California Saturday, April 5, 2025, 11:00 Hrs [IST] Amgen announced that the US Food and Drug Admin ...